GRANT=6446816;P01AG The major goal of the Core is to provide support for subprojects: These services will include the following: metabolic studies (euglycemic and hyperglycemic glucose clamps,, tracer turnover studies), regional and tody body composition, muscle histological and cytosine analysis, muscle formation, functional status, resulting energy expenditure, and relevant study questionnaires. In addition, oversight of the Data Safety and Monitoring board is the responsibility of the Core. The Core will apply standardized methods with quality assurance mechanisms to maximize data quality and minimize methodological variation and measurement drift. The centralized organization will ensure financial stability, expert quality control and availability of services to all study investigators. The core will be responsible for providing the statistical analyses that are required. The tests performed by this Core are ones that are well established at the Massachusetts General Hospital and the Nutrition, Exercise Physiology, and Sarcopenia (NEPS) and Body Composition Laboratories at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University. Thus, there is a wealth of experience on the part of the investigators in uses and limitations of these methods. Opportunities to learn methodological procedures and techniques operation in the core will be available to postdoctoral and junior faculty interested in Clinical research.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG000599-20A2
Application #
6446816
Study Section
Special Emphasis Panel (ZAG1)
Project Start
1977-07-01
Project End
2006-11-30
Budget Start
Budget End
Support Year
20
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Elahi, Dariush; Ruff, Dennis A; Carlson, Olga D et al. (2016) Does GLP-1 suppress its own basal secretion? Endocr Res 41:16-20
Elahi, Dariush; Angeli, Franca S; Vakilipour, Amin et al. (2014) GLP-1(32-36)amide, a novel pentapeptide cleavage product of GLP-1, modulates whole body glucose metabolism in dogs. Peptides 59:20-4
Ahmed, Sofia B; Bentley-Lewis, Rhonda; Hollenberg, Norman K et al. (2009) A comparison of prediction equations for estimating glomerular filtration rate in pregnancy. Hypertens Pregnancy 28:243-55
Abu-Hamdah, Rania; Rabiee, Atoosa; Meneilly, Graydon S et al. (2009) Clinical review: The extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 94:1843-52
Moore, T J; Rich, G; McKnight, J A et al. (1996) Salt sensitivity of hypertension and responses to angiotensin converting enzyme inhibition with benazepril. Am J Hypertens 9:54-60
Hollenberg, N K; Moore, T J (1994) Age and the renal blood supply: renal vascular responses to angiotensin converting enzyme inhibition in healthy humans. J Am Geriatr Soc 42:805-8
Allan, D R; McKnight, J A; Kifor, I et al. (1994) Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension 24:516-22
Bauer, K A; Kass, B L; ten Cate, H et al. (1990) Factor IX is activated in vivo by the tissue factor mechanism. Blood 76:731-6
Lee, J K; Gordon, P R; Stall, G M et al. (1989) Phenolic and tyrosyl ring iodothyronine deiodination by the Caco-2 human colon carcinoma cell line. Metabolism 38:1154-61
Bauer, K A; Weiss, L M; Sparrow, D et al. (1987) Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J Clin Invest 80:1527-34